Effective price: ₹19437
WHOLE BLOOD EDTA
All age group
PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL is a genetic test that detects mutations in the BRCA1 and BRCA2 genes. These genes play a crucial role in suppressing tumour growth and preventing the development of breast and ovarian cancers. Mutations in these genes can increase the risk of developing these cancers significantly. This test is recommended for individuals with a family history of breast or ovarian cancer or those who have been diagnosed with these cancers before the age of 50.
The PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL involves a simple blood test. A laboratory technician will draw a small sample of blood from a vein in your arm. No special preparation is required for this test.
At the lab, the DNA extracted from the blood sample is analysed to look for mutations in the BRCA1 and BRCA2 genes. This test uses the ONCOMINE BRCA1 AND BRCA2 ASSAY (GERMLINE) technology, which is highly accurate and reliable. The sample will be sent to a specialized laboratory, and the results will be available within 22 days.
If an individual tests positive for the mutations in the BRCA1 or BRCA2 genes, there are several options available. These may include increased surveillance, preventive measures such as prophylactic surgery, or targeted therapies that may reduce cancer risk. A positive test result can also provide important information for family members who may also be at increased risk of developing cancer.
The PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL price is usually on the higher side. However, this can be explained by the extreme technical precision, accurate and well-calibrated instruments, and careful sample handling needed for the test. In such cases, you should only opt for a trusted diagnostic partner like Apollo 24|7.
Individuals who want to opt for the PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL can book their slot on the Apollo 24|7 website or app. Opting for PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL at Apollo 24|7 can offer several benefits, the most major one being a high accuracy of diagnosis. The results of the PRECISO BRCA1 & 2 HEREDITARY (GERMLINE) PANEL at Apollo 24|7 are made available within 22 days.
Early diagnosis is crucial in preventing or effectively treating cancers. It can help reduce costs associated with the treatment of advanced-stage cancers and ensure better treatment outcomes. For a timely intervention, book your test at Apollo 24|7 today.
Why should Apollo be your preferred healthcare partner?
The information mentioned above is meant for educational purposes only and should not be taken as a substitute to your Physician’s advice. It is highly recommended that the customer consults with a qualified healthcare professional to interpret test results